Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate? Maryanne Demasi investigates
From FDA to MHRA: are drug regulators for hire?
Tag: Medicines and Healthcare products Regulatory Agency
EU: Possible link between Covid vaccines and menstrual disorders prompts investigation
Covid-19 vaccines and treatments: we must have raw data, now
Regulators prohibit Pfizer vaccine for people with ‘significant’ allergies after two NHS staff suffer reactions
“And as an illustration to this, I may share with the committee that even last evening we were looking at two case reports of allergic reactions. We know from the very extensive clinical trials that this wasn’t a feature. But if we need to strengthen our advice…. we get that advice to the field immediately.”
Ms. Cat’s Chronicles 